Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Malignant mesenchymal tumor × Imatinib Mesylate × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 33 Leukemia 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 15 Leukemia, Myeloid, Chronic-Phase 12 Gastrointestinal Stromal Tumors 12 Philadelphia Chromosome 5 Leukemia, Myeloid 5 Brain Neoplasms 5 Carcinoma, Non-Small-Cell Lung 4 Blast Crisis 4 Recurrence 3 Prostatic Neoplasms 3 Melanoma 3 Lung Neoplasms 3 Leukemia, Myeloid, Acute 3 Hematologic Diseases 3 Glioblastoma 3 Bone Marrow Diseases 3 Stomach Neoplasms 2 Sarcoma 2 Ovarian Neoplasms 2 Neoplasms by Histologic Type 2 Neoplasm Metastasis 2 Myeloproliferative Disorders 2 Meningioma 2 Leukemia, Myeloid, Accelerated Phase 2 Gliosarcoma 2 Glioma 2 Digestive System Neoplasms 2 Carcinoma, Renal Cell 2

Interventions

Radiotherapy, Conformal 2 Ifosfamide 2 Doxorubicin 2 romidepsin 1 indolepropanol phosphate 1 etoposide phosphate 1 Watchful Waiting 1 Vincristine 1 Sunitinib 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy 1 Polymerase Chain Reaction 1 Observation 1 Neoadjuvant Therapy 1 Irinotecan 1 HhAntag691 1 Granulocyte Colony-Stimulating Factor 1 Gene Expression Profiling 1 Filgrastim 1 Etoposide 1 Dactinomycin 1 Cyclophosphamide 1 Blotting, Western 1 2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡